Re-Assessing EBS CEO Kramer's Recent Planned Sales
Emergent BioSolutions Inc. (EBS) CEO and President Robert Kramer has been in the news recently due to the company's issues related to the production of the Coronavirus vaccine. In light of recent developments, we re-assess Kramer's planned selling from earlier this year.
Large Transaction: NVDA Director Sells $30 Million
On June 10, shares of NVIDIA Corp. (NVDA) hit an all-time high of $380, due in part to a late May report of first quarter earnings and revenue that exceeded analysts' expectations. Between June 19 and July 2, Director Mark A. Stevens indirectly sold a total of 79,381 shares through his trust at an average price 0.3% above the high. As seen on the graph below, the aggregate $30. ...